Jon P. Stonehouse
2018
Compensation breakdown
| Non-Equity Incentive Plan | $325,188 |
|---|---|
| Option Awards | $3,277,800 |
| Salary | $550,000 |
| Other | $14,655 |
| Total | $4,167,643 |
Stonehouse received $3.3M in option awards, accounting for 79% of the total pay in 2018.
Stonehouse also received $325.2K in non-equity incentive plan, $550K in salary and $14.7K in other compensation.
Rankings
In 2018, Jon P. Stonehouse's compensation ranked 2,637th out of 14,244 executives tracked by ExecPay. In other words, Stonehouse earned more than 81.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,637 out of 14,244 | 82nd |
Division Manufacturing | 977 out of 5,765 | 83rd |
Major group Chemicals And Allied Products | 333 out of 2,128 | 84th |
Industry group Drugs | 271 out of 1,817 | 85th |
Industry Biological Products, Except Diagnostic Substances | 55 out of 339 | 84th |
Pay ratio
| Jon P. Stonehouse's Pay | $4,167,643 |
|---|---|
| Median Employee's Pay | $205,224 |
| Pay Ratio | 20to 1 |
In 2018, the annual total compensation of Jon P. Stonehouse was $4,167,643.
The annual total compensation of the median employee at BioCryst Pharmaceuticals was $205,224.
The ratio of Jon P. Stonehouse's pay to the pay of median employee was therefore 20 to one.
Stonehouse's colleagues
We found four more compensation records of executives who worked with Jon P. Stonehouse at BioCryst Pharmaceuticals in 2018.
2018
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2018
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2018
Yarlagadda Babu
BioCryst Pharmaceuticals
Senior Vice President of Drug Discovery
2018
Lynne Powell
BioCryst Pharmaceuticals